Literature DB >> 19874873

Contralateral paw sensitization following injection of endothelin-1: effects of local anesthetics differentiate peripheral and central processes.

A Khodorova1, G R Strichartz.   

Abstract

Subcutaneous injection of the peptide endothelin-1 (ET-1) into the rat's footpad is known to cause rapid, transient ipsilateral mechanical and thermal sensitization and nocifensive hind paw flinching. Here we report that local injection of ET-1 (2 nmoles) into one hind paw slowly sensitizes the contralateral paw to chemical and mechanical stimulation. There was a 1.5-2-fold increase in the hind paw flinching response, over that from the first injection, to a second injection of the same dose of ET-1 delivered 24 h later into the contralateral paw. A similar increase in the number of flinches during the second phase of the response to formalin also occurred in the contralateral paw 24 h after ET-1. The contralateral paw withdrawal threshold to von Frey hairs was lowered by approximately 55% at 24 h after ipsilateral ET-1 injection. ET-1 injected s.c. at a segmentally unrelated location, the nuchal midline, caused no sensitization of the paws, obviating a systemic route of action. Local anesthetic block of the ipsilateral sciatic nerve during the period of initial response to ipsilateral ET-1 prevented contralateral sensitization, indicating the importance of local afferent transmission, although ipsilateral desensitization was not changed. These findings suggest that peripheral ET-1 actions lead to central sensitization that alters responses to selected stimuli.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19874873      PMCID: PMC2795047          DOI: 10.1016/j.neuroscience.2009.10.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  49 in total

1.  Myelinated afferents signal the hyperalgesia associated with nerve injury.

Authors:  James N Campbell; Srinivasa N Raja; Richard A Meyer; Susan E Mackinnon
Journal:  Pain       Date:  1988-01       Impact factor: 6.961

2.  Neurogenic influences on contralateral responses during experimental rat monoarthritis.

Authors:  B L Kidd; S C Cruwys; N E Garrett; P I Mapp; V A Jolliffe; D R Blake
Journal:  Brain Res       Date:  1995-08-07       Impact factor: 3.252

3.  Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity.

Authors:  S Puig; L S Sorkin
Journal:  Pain       Date:  1996-02       Impact factor: 6.961

4.  Receptor externalization determines sustained contractile responses to endothelin-1 in the rat aorta.

Authors:  R Marsault; E Feolde; C Frelin
Journal:  Am J Physiol       Date:  1993-03

5.  Thermal hyperalgesia accelerates and MK-801 prevents the development of tachyphylaxis to rat sciatic nerve blockade.

Authors:  K C Lee; R T Wilder; R L Smith; C B Berde
Journal:  Anesthesiology       Date:  1994-11       Impact factor: 7.892

6.  Desensitization of human endothelin A receptor.

Authors:  C Cyr; R M Kris
Journal:  J Cardiovasc Pharmacol       Date:  1993       Impact factor: 3.105

7.  Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats.

Authors:  S R Chaplan; F W Bach; S L Shafer; T L Yaksh
Journal:  Anesthesiology       Date:  1995-10       Impact factor: 7.892

8.  Acute endoneurial ischemia induced by epineurial endothelin in the rat sciatic nerve.

Authors:  D W Zochodne; L T Ho; P M Gross
Journal:  Am J Physiol       Date:  1992-12

9.  Nerve growth factor contributes to the up-regulation of growth-associated protein 43 and preprotachykinin A messenger RNAs in primary sensory neurons following peripheral inflammation.

Authors:  T A Leslie; P C Emson; P M Dowd; C J Woolf
Journal:  Neuroscience       Date:  1995-08       Impact factor: 3.590

10.  Effects of endothelin-1 on capsaicin-induced nociception in mice.

Authors:  A P Piovezan; P D'Orléans-Juste; C R Tonussi; G A Rae
Journal:  Eur J Pharmacol       Date:  1998-06-12       Impact factor: 4.432

View more
  2 in total

1.  Effects of repeated central administration of endothelin type A receptor antagonist on the development of neuropathic pain in rats.

Authors:  Lydia W Tai; Victor K L Hung; Wei Mei; Qiu Qiu; Sookja K Chung; C W Cheung
Journal:  Biomed Res Int       Date:  2013-08-29       Impact factor: 3.411

Review 2.  Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain.

Authors:  Terika P Smith; Tami Haymond; Sherika N Smith; Sarah M Sweitzer
Journal:  J Pain Res       Date:  2014-08-30       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.